300 related articles for article (PubMed ID: 10602420)
21.
Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
[No Abstract] [Full Text] [Related]
22. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
[TBL] [Abstract][Full Text] [Related]
23. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes.
Fujino T; Yamazaki Y; Largaespada DA; Jenkins NA; Copeland NG; Hirokawa K; Nakamura T
Exp Hematol; 2001 Jul; 29(7):856-63. PubMed ID: 11438208
[TBL] [Abstract][Full Text] [Related]
25. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.
Schnabel CA; Jacobs Y; Cleary ML
Oncogene; 2000 Feb; 19(5):608-16. PubMed ID: 10698505
[TBL] [Abstract][Full Text] [Related]
26. Identification of a conserved family of Meis1-related homeobox genes.
Steelman S; Moskow JJ; Muzynski K; North C; Druck T; Montgomery JC; Huebner K; Daar IO; Buchberg AM
Genome Res; 1997 Feb; 7(2):142-56. PubMed ID: 9049632
[TBL] [Abstract][Full Text] [Related]
27. Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.
Beachy SH; Onozawa M; Silverman D; Chung YJ; Rivera MM; Aplan PD
Exp Hematol; 2013 Jun; 41(6):518-529.e5. PubMed ID: 23435313
[TBL] [Abstract][Full Text] [Related]
28. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
[TBL] [Abstract][Full Text] [Related]
29. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
[No Abstract] [Full Text] [Related]
30. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
31. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
32. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
[TBL] [Abstract][Full Text] [Related]
33. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.
Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G
Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201
[TBL] [Abstract][Full Text] [Related]
34. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
Calvo KR; Sykes DB; Pasillas M; Kamps MP
Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
[TBL] [Abstract][Full Text] [Related]
35. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
[TBL] [Abstract][Full Text] [Related]
36. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
[TBL] [Abstract][Full Text] [Related]
37. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.
He M; Chen P; Arnovitz S; Li Y; Huang H; Neilly MB; Wei M; Rowley JD; Chen J; Li Z
Blood Cells Mol Dis; 2012 Aug; 49(2):102-6. PubMed ID: 22633751
[TBL] [Abstract][Full Text] [Related]
38. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.
Yokoyama T; Nakatake M; Kuwata T; Couzinet A; Goitsuka R; Tsutsumi S; Aburatani H; Valk PJ; Delwel R; Nakamura T
J Clin Invest; 2016 May; 126(5):1664-78. PubMed ID: 27018596
[TBL] [Abstract][Full Text] [Related]
39. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
[TBL] [Abstract][Full Text] [Related]
40. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
Collins CT; Hess JL
Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
